» Articles » PMID: 21804561

Cell-surface Markers for the Isolation of Pancreatic Cell Types Derived from Human Embryonic Stem Cells

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2011 Aug 2
PMID 21804561
Citations 170
Authors
Affiliations
Soon will be listed here.
Abstract

Using a flow cytometry-based screen of commercial antibodies, we have identified cell-surface markers for the separation of pancreatic cell types derived from human embryonic stem (hES) cells. We show enrichment of pancreatic endoderm cells using CD142 and of endocrine cells using CD200 and CD318. After transplantation into mice, enriched pancreatic endoderm cells give rise to all the pancreatic lineages, including functional insulin-producing cells, demonstrating that they are pancreatic progenitors. In contrast, implanted, enriched polyhormonal endocrine cells principally give rise to glucagon cells. These antibodies will aid investigations that use pancreatic cells generated from pluripotent stem cells to study diabetes and pancreas biology.

Citing Articles

Controlling human stem cell-derived islet composition using magnetic sorting.

Kelley A, Shunkarova M, Maestas M, Gale S, Hogrebe N, Millman J bioRxiv. 2024; .

PMID: 39605713 PMC: 11601561. DOI: 10.1101/2024.11.19.624394.


Pancreatic islet transplantation: current advances and challenges.

Wang Q, Huang Y, Liu L, Zhao X, Sun Y, Mao X Front Immunol. 2024; 15:1391504.

PMID: 38887292 PMC: 11180903. DOI: 10.3389/fimmu.2024.1391504.


Advances and challenges of the cell-based therapies among diabetic patients.

Raoufinia R, Rahimi H, Saburi E, Moghbeli M J Transl Med. 2024; 22(1):435.

PMID: 38720379 PMC: 11077715. DOI: 10.1186/s12967-024-05226-3.


Development of synthetic modulator enabling long-term propagation and neurogenesis of human embryonic stem cell-derived neural progenitor cells.

Liao C, Guan Y, Zheng J, Wang X, Wang M, Zhu Z Biol Res. 2023; 56(1):59.

PMID: 37951961 PMC: 10638775. DOI: 10.1186/s40659-023-00471-0.


A critical review on therapeutic approaches of CRISPR-Cas9 in diabetes mellitus.

Bora J, Dey A, Lyngdoh A, Dhasmana A, Ranjan A, Kishore S Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(12):3459-3481.

PMID: 37522916 DOI: 10.1007/s00210-023-02631-1.


References
1.
DAmour K, Bang A, Eliazer S, Kelly O, Agulnick A, Smart N . Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006; 24(11):1392-401. DOI: 10.1038/nbt1259. View

2.
Miyazawa Y, Uekita T, Hiraoka N, Fujii S, Kosuge T, Kanai Y . CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation. Cancer Res. 2010; 70(12):5136-46. DOI: 10.1158/0008-5472.CAN-10-0220. View

3.
Dorrell C, Abraham S, Lanxon-Cookson K, Canaday P, Streeter P, Grompe M . Isolation of major pancreatic cell types and long-term culture-initiating cells using novel human surface markers. Stem Cell Res. 2009; 1(3):183-94. DOI: 10.1016/j.scr.2008.04.001. View

4.
Guo T, Hebrok M . Stem cells to pancreatic beta-cells: new sources for diabetes cell therapy. Endocr Rev. 2009; 30(3):214-27. PMC: 2726841. DOI: 10.1210/er.2009-0004. View

5.
Wilson M, Kalamaras J, German M . Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas. Mech Dev. 2002; 115(1-2):171-6. DOI: 10.1016/s0925-4773(02)00118-1. View